Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Biontech Se ADR (BNTX)

Biontech Se ADR (BNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Here's Why Everyone's Talking About Summit Therapeutics Motley Fool - Tue Sep 17, 3:24AM CDT

Find out why positive results from a Summit Therapeutics study keep pushing up BioNTech and Instil Bio stock.

SMMT : 24.61 (-6.14%)
TIL : 70.58 (+8.94%)
BNTX : 116.12 (-6.89%)
Should You Buy Novavax Stock After This Regulatory Win? Motley Fool - Fri Sep 13, 6:50AM CDT

The biotech continues to earn important wins, but is it enough?

MRNA : 70.29 (-2.36%)
BNTX : 116.12 (-6.89%)
JNJ : 166.41 (-0.40%)
PFE : 29.75 (-0.27%)
NVAX : 12.70 (-1.78%)
SNY : 57.23 (+0.56%)
Analysts Predict Strong Growth for Cancer Vaccine Market: Key Biotech Stocks to Consider BayStreet.ca - Wed Sep 4, 11:39AM CDT

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – Back in 2022, Nature published...

BIOV.CN : 0.0650 (+8.33%)
BVAXF : 0.0445 (-1.11%)
BNTX : 116.12 (-6.89%)
CVAC : 3.27 (-0.30%)
VXRT : 0.9002 (-2.63%)
IBRX : 3.43 (+3.31%)
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth FinancialNewsMedia - Wed Sep 4, 8:15AM CDT

EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:NVAX),(NASDAQ:RGNX),(NASDAQ:BNTX),(NYSE:ABBV) EQNX::TICKER_END

SBFM : 2.98 (+5.30%)
NVAX : 12.70 (-1.78%)
RGNX : 12.42 (-4.09%)
BNTX : 116.12 (-6.89%)
ABBV : 192.99 (-0.24%)
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth GlobeNewswire - Wed Sep 4, 8:15AM CDT

SBFM : 2.98 (+5.30%)
NVAX : 12.70 (-1.78%)
RGNX : 12.42 (-4.09%)
BNTX : 116.12 (-6.89%)
ABBV : 192.99 (-0.24%)
Pfizer and BioNTech's Combo Shot Missed the Mark. Is It Time to Sell? Motley Fool - Mon Aug 19, 3:07AM CDT

A clinical-trial failure for Pfizer and BioNTech means Moderna is leading the race to develop a combo shot for the flu and COVID-19.

PFE : 29.75 (-0.27%)
BNTX : 116.12 (-6.89%)
MRNA : 70.29 (-2.36%)
Why Pfizer Stock Slumped on Friday Motley Fool - Fri Aug 16, 5:38PM CDT

Investors were cautiously pessimistic about the latest news coming out of the company's lab.

BNTX : 116.12 (-6.89%)
PFE : 29.75 (-0.27%)
BioNTech Se (BNTX) Q2 2024 Earnings Call Transcript Motley Fool - Mon Aug 5, 1:30PM CDT

BNTX earnings call for the period ending June 30, 2024.

BNTX : 116.12 (-6.89%)
Pfizer Raises Forecast on Robust Drug Sales, Offsets COVID-19 Revenue Decline Quiver Quantitative, Inc. - Tue Jul 30, 10:14AM CDT

Pfizer (PFE) raised its annual profit forecast, driven by robust sales in its cancer and heart disease drug segments, particularly benefiting from its recent acquisition of Seagen. The pharmaceutical giant...

SGEN : 228.74 (-0.07%)
BNTX : 116.12 (-6.89%)
JPM : 207.82 (-0.68%)
Biotech Innovations Drive Pancreatic Cancer Treatment: Market Expected to Reach $7.4 Billion by 2032 BayStreet.ca - Mon Jun 3, 8:33AM CDT

USA News Group – Recognized as one of the most lethal cancers, researchers are striving to improve survival rates for pancreatic cancer patients by focusing on earlier detection. According to Johns Hopkins...

ONCY : 0.9300 (-2.99%)
ONC.TO : 1.28 (-1.54%)
VSTM : 2.72 (-2.16%)
CTMX : 1.2000 (-0.83%)
BNTX : 116.12 (-6.89%)
FGEN : 0.4305 (-3.93%)

Barchart Exclusives

Dividend Aristocrats: The Best of the Best for Stable Income Barchart - 27 minutes ago
Dividend Aristocrats' ability to increase their dividends indicates strong earnings and a solid business foundation, which lowers investment risk. Moreover, their consistent earnings growth often enables them to outperform broader market indices. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot